OM:BONEXBiotechs
Assessing Bonesupport Holding (OM:BONEX) Valuation After New CERAMENT G US Pilot Study Results
Clinical pilot results put CERAMENT G in the spotlight
Bonesupport Holding (OM:BONEX) is back on investors’ radars after announcing first US clinical pilot data for CERAMENT G in trauma, with the study reporting infection free healing and radiographic union across all followed cases.
See our latest analysis for Bonesupport Holding.
The CERAMENT G pilot results arrive after a choppy period for the stock, with a 7.9% decline in the 7 day share price return, a 7.9% gain on the 1 month share...